2018
DOI: 10.1111/dme.13766
|View full text |Cite
|
Sign up to set email alerts
|

Variations in access to and reimbursement for continuous glucose monitoring systems for people living with Type 1 diabetes across England

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
16
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
8

Relationship

2
6

Authors

Journals

citations
Cited by 12 publications
(16 citation statements)
references
References 7 publications
0
16
0
Order By: Relevance
“…Although there are no national figures on uptake for RT-CGM, even with the current restricted criteria, there is considerable variation in access in England with the majority of clinical commissioning groups (CCGs) having to use labour-intensive Individual Funding Requests to gain access to RT-CGM. 29 Managing CGM in the acute setting Users of CGM admitted to hospital should be encouraged to selfmanage their devices. However, healthcare professionals should be aware of the indications for CGM and be vigilant to the risk of hypoglycaemia in this cohort.…”
Section: Real-time Continuous Glucose Monitoringmentioning
confidence: 99%
“…Although there are no national figures on uptake for RT-CGM, even with the current restricted criteria, there is considerable variation in access in England with the majority of clinical commissioning groups (CCGs) having to use labour-intensive Individual Funding Requests to gain access to RT-CGM. 29 Managing CGM in the acute setting Users of CGM admitted to hospital should be encouraged to selfmanage their devices. However, healthcare professionals should be aware of the indications for CGM and be vigilant to the risk of hypoglycaemia in this cohort.…”
Section: Real-time Continuous Glucose Monitoringmentioning
confidence: 99%
“…The criteria include: >1 episode of severe hypoglycaemia/year; complete loss of awareness of hypoglycaemia; hypoglycaemia that is causing problems with daily activities; extreme fear of hypoglycaemia; and HbA 1c ≥ 75mmol/mol (≥ 9.0%) despite testing ≥ 10 times/day [2]. Variations in funding through local payer organizations results in CGM use being varied and limited [23]. Even within a reimbursed healthcare system, however, other barriers to CGM limit uptake, including alarm fatigue, concerns about accuracy, and physical discomfort.…”
Section: Subcutaneous Amperometric Needle-type Sensorsmentioning
confidence: 99%
“…However, there is no mandate for funding, and the majority of diabetes care facilities have no policy to allow those meeting NICE criteria to access funding [ 13 ]. Variations and disparities in accessing diabetes technologies and T1DM care are also evident in England and Wales [ 14 , 15 ]. Given the immediate need to improve outcomes for T1DM care in England and Wales, improving access to technologies needs to be an important priority for the National Health Service [ 16 ].…”
Section: Physician Perspectivementioning
confidence: 99%